Emeryville, CA synthetic biology company Amyris Biotechnologies raised $24.7 million in the first close of a Series C this week from existing investors including Khosla Ventures, Kleiner Perkins Caufield & Byers,...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)